International Journal of Radiation Oncology*Biology*Physics
Brief commnunicationRadiotherapy, combined with simulataneous chemotherapy with Mitomycin C and bleomycin for inoperable head and neck cancer—preliminary report
References (46)
- et al.
Intra-arterial Mitomycin C and intravenous Bleomycin as induction chemotherapy in advanced head and neck cancer—A phase II study
Radiother. Oncol.
(1986) - et al.
Preliminary results of a randomized EORTC study comparing radiotherapy and concomitant Bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx
Eur. J. Cancer
(1977) Unconventional fractionation with or without Mitomycin C in advanced head and neck cancer
Semin. Oncol.
(1992)- et al.
Mode of interaction of 5-Fluorouracil, radiation and Mitomycin C: In vitro studies
Int. J. Radiat. Oncol. Biol. Phys.
(1992) - et al.
Response to preoperative concomitant radiochemotherapy with Mitomycin C and 5-Fluorouracil in advanced head and neck cancer
Eur. J. Cancer Clin. Oncol.
(1989) - et al.
Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
Int. J. Radiat. Oncol. Biol. Phys.
(1988) - et al.
A randomized clinical trial to contrast radiotherapy with radiotherapy and Methotrexate given synchronously in head and neck cancer
Clin. Radiol.
(1987) - et al.
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials
Int. J. Radiat. Oncol. Biol. Phys.
(1993) - et al.
Combined preoperative treatment with cobalt and Bleomycin in patients with head and neck carcinoma—A controled clinical study
Int. J. Radiat. Oncol. Biol. Phys.
(1978) - et al.
Combined therapy of oral cancer with Bleomycin and radiation; A clinical trial
Clin. Radiol.
(1977)
Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: A phase III clinical trial
Int. J. Radiat. Oncol. Biol. Phys.
Randomized clinical trial of Mitomycin C as an adjunct to radiotherapy in head and neck cancer
Int. J. Radiat. Oncol. Biol. Phys.
Concurent split-course radiation and chemotherapy using 5-Fluorouracil and Mitomycin C in locally advanced head and neck cancer
Ann. Oncol.
Simultaneous vs. sequential combined technique therapy for squamous cell head and neck cancer
Cancer Res.
Manual for staging of cancer
Statistical methods in medical research
Chemotherapy with synchronization in advanced cancer of the head and neck
Radiol. Iugosl.
Intravenous chemotherapy with synchronization in advanced cancer of oral cavity and oropharynx
Z. Krebsforsch.
BMDP statistical software
Adjuvant chemotherapy of head and neck cancer: The past, the present and the future
Semin. Oncol.
Ten-year results of randomized trial comparing radiotherapy and concomitant Bleomycin to radiotherapy alone in epidermoid carcinoma of the oropharynx: Experience of the European Organization for Research and Treatment of Cancer
Natl. Cancer Inst. Monogr.
Final report of Head and neck contracts program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma
Cancer
Cited by (60)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
2021, Radiotherapy and OncologyCitation Excerpt :With adjustment on sex and age, results were still significant for OS (p = 0.02) and borderline for EFS (p = 0.05). Seventy-one concomitant comparisons were available to evaluate the effect of concomitant chemotherapy (10,680 patients, 7944 deaths, cause of death in Web-Table 8) with a median follow-up of 9.2 years (IQR: 5.2; 12.9) [17,20–22,31–34,36,56,75–123]. The HR of death (Fig. 1A, Web-Fig. 10) was 0.83 [95% CI: 0.79; 0.86] (p < 0.0001) in favour of concomitant chemotherapy with an absolute benefit of 6.5% at 5 years and 3.6% at 10 years (Fig. 2B).
Concomitant Chemoradiotherapy With Mitomycin C and Cisplatin in Advanced Unresectable Carcinoma of the Head and Neck: Phase I-II Clinical Study
2008, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :Because more than only an additive effect of mitomycin C can be expected when combined with XRT, a double dose of irradiation on the day of drug application was planned (20). Favorable clinical results gained through prospective clinical trials conducted in our institution (21, 22) and by others (23–25) warranted our choice. Cisplatin was given in the last 2 weeks of XRT to counteract the accelerated repopulation of surviving tumor clonogens.
Cisplatin-based chemotherapy: The only alternative in chemoradiation of head and neck cancer? Experience of the Institute of Oncology, Ljubljana, Slovenia
2007, Reports of Practical Oncology and RadiotherapyTreatment of carcinoma of the oral cavity with radical and postoperative radiotherapy at the Institute of Oncology Ljubljana, 1990-1995
2007, Reports of Practical Oncology and RadiotherapyConcurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: Final results of a randomized clinical trial
2005, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :In primary radiation patients, Zakotnik reported an improvement in overall survival (26% vs. 7%) and disease-free survival (48% vs. 10%) in the MC arms (60). In postoperative patients from the same group, Smid et al. reported an improvement in local-regional control (86% vs. 69%) and overall survival (74% vs. 63%) in the drug-treated arm (15). Collectively these studies support a therapeutic gain when MC is combined with radiation therapy in the management of SCCHN.